Figure 2
Event-free and overall survival for all patients in accelerated phase. (A) Event-free survival by IC50 in accelerated phase. (B) Overall survival by IC50 in accelerated phase.
Event-free and overall survival for all patients in accelerated phase. (A) Event-free survival by IC50 in accelerated phase. (B) Overall survival by IC50 in accelerated phase.
